Mylan gets DCGI nod for remdesivir in India, to launch at Rs...

Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir...

Gilead Sciences to start trials of inhaled version of remdesivir

California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials...

Six Indian companies applied to CDSCO for permission to...

New Delhi [India], June 14 (ANI): The Centre on Sunday said that six Indian companies -- Hetero, Cipla, BDR,...

Dr Reddy's Labs in licensing pact with Gilead Sciences for...

Hyderabad (Telangana) [India], June 13 (ANI): Dr Reddy's Laboratories said on Saturday it has entered into a...

Zydus signs licensing agreement with Gilead to manufacture...

Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing...

'US' current supply of Remdesivir to get exhausted by end of June'

Washington DC [USA], June 8 (ANI): The US government's current supply of Remdesivir, the only drug till now known to...

COVID-19: Remdesivir gets nod from CDCSO for 'restricted...

New Delhi [India], June 2 (ANI): In a significant development, the country's top drug controller the Central Drug...

Coronavirus: Too early to discuss pricing of remdesivir, says...

Washington DC [USA], May 28 (ANI): The Department of Health and Human Services has said that it is too early to...

Jubilant Life Sciences surges 5 pc after signing deal with...

Mumbai (Maharashtra) [India], May 13 (ANI): The share price of Jubilant Life Sciences surged 5 per cent hitting...

COVID-19: Cipla enters into licensing pact with Gilead to...

Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a...

Gilead in talks with Indian drugmakers to produce remdesivir...

New Delhi [India], May 6 (ANI): US-based biopharmaceutical major Gilead Sciences said on Wednesday it is negotiating...

India can easily do synthesis of antiviral drug - Remdesivir:...

New Delhi [India], May 3 (ANI): India can easily do the synthesis of antiviral drug - Remdesivir - if allowed by the...